Thanks steveh8000. You're an inspiration to us all and we'll sure miss you. It's not often a board is graced by the presence of someone like yourself. Your sage advice, steady hand, calm demeanor, and: "tell it like it is" approach to investing is a model most folks just aspire to. But you? It just looks effortless when you do what you do which is the correct thing, 100% of the time.
I'm going to write a letter to the exchanges. The submission will request that beside a bronzed bull & bear, that the amazing feature - an additional bronze be added of you, steveh8000, with your likeness having one hand man-handling the bull by a horn and the other squeezing the testicles of the bear. That's what you've done since investing in ARNA; you've handled things in both directions in a way most tradebots only dream.
So here's to YOU steveh8000!! A man amongst animals, a beast amid demons, and last but not least -- the guy the rest of us only WISH we could be. From here forward you will be affectionately referred to as: "God's personal broker." Because that's what you are.
Will you be signing autographed pictures in the lobby? If so, do give the location of the hotel. I'd like to cherish your image in my office's wall. A reminder when I'm thinking of hitting the buy or sell button. So that perhaps in the moments of chaos I can reflect awhile and throw the hard questions into The Universe and summon a consciousness to bring into focus, what is always the prized answer to the eternal question that goes well-beyond what is otherwise just a stock transaction, but addresses all things in life: "What would steveh8000 do?"
I bid you farewell my friend. Happy trails (whatever that means) and may the best always be just around the corner into where you turn next.
Hi boundbrook67, if you search the title of the article it comes up. The title of the article is the last sentence, and here it is again: Parkinson's link to statins Calls to end widespread use of the drug
this is the title of the article, just curious what it might mean for AMRN if anybody knows?
Parkinson's link to statins Calls to end widespread use of the drug
The drug is intolerable and lacks commercial viability beyond somebody taking it out of curiosity who doesn't yet know how it will make them feel while they are on it. Why do you suppose so many people drop out of their studies? Why? Is that a random chance thing with congrave or is there a pattern to it? On what basis is a sales force going to viably, over the long term, pay for itself when they're pimping a cheap and crude generic combination that puts upon an insufferable experience to the big majority of its users?
Have you ever taken Belviq and added phen with it? You feel awesome and it's a miracle and it's the best drug ever invented. But you think what again is the reason to defend OREX here when we have Belviq and an amazing pipeline and no troubles germinating with the FDA?
Who is going to be buying that bagpile OREX when its only compound is an insufferable attempt at an obesity solution from a pair of dangerous generics and it wont even be able to pay for a sales force long term? It's worthless! A waste of time. And radioactive!
Think about it.
Sentiment: Strong Buy
3/05/2015 @ 5:28PM - Forbes
The investment houses are apparently unloading this onto mom & pop right now. This has lawsuits galore written all over it. imo
Sentiment: Strong Sell
I'll take ENVI (Envivio) for $1.40 Alex. Plus, on the date you're selecting 2-20-2015 it might even be better than now.
Several of those indications for Ralinepag are also cited as treatable indications in other drugs currently under development at ARNA. I wonder, and presuming great safety profiles, how many of in-house drugs under development at Arena might be combined to amplify efficacy and treat altogether separate indications beyond their first approved indication?
For instance, Ralinepag is expected to be used in combination for PAH with the other drugs. Apparently it also has an effect upon rheumatoid arthritis; I see rheumatoid arthritis listed as being treatable with other drugs in the ARNA pipeline. What synergies might be accomplished with two (or more) patented compounds, being developed in-house at Arena, to make new drugs for shared but separate indications?
Now THAT would be something. Sure it's down the road. But that would provide some seriously drawn-out life cycles for the ARNA drugs actively in program. So the case can be made those revenues are so far down the road they don't enter the equation in today's price. Okay. But if you are in a situation where a suitor comes along and wants to buy you? Like Pfizer as an example? The value of that sort of thing really ups the ante insofar as long-term value is punctuated.
I would also figure the only ones sufficiently knowledgeable as to what enhances the treatment to different indications in a meaningful way with Arena's drugs under development would be the folks inside Arena only. Then again, maybe somebody could shed light upon it? It would take a deep understanding though, of what synergies are beneficial toward separate conditions.
Sentiment: Strong Buy
He has more money than he needs by a long shot if all he seeks is living comfortably. Beyond comfort comes self-actualization. If he is fulfilling a lifetime body of work, he will wait for $37+ or he will say, we did it our way. Integrity or despair is where folks minds are when they die. I'm sure you being such a close friend to him, well, why don't you just call him a whore to his face?
Sentiment: Strong Buy
I'm an old guy and this is yahoo. Sorry to disappoint you.
Maybe you should pick up a blunt. You know, it might cheer you up which it sounds like you could use some of that.
Why are yeh so bummed-out? I'm just feckun around. It's good to just goof around occasionally you know. Nobody gets hurt. Nobody should care. Why aren't you watching football? I'm here because my wife is asleep so just watching the game and trolling these boards.
Why not call that: "Belvederrier?"
belvedere = cigar; Derriere = buttocks
Quit smoking but don't launch a BIG O' phatass because you lose weight even though you quit smoking and of course, the: "BELV" has, umm, Belviq's essence. Then again there are a lot of super-skinny people who smoke with leather skin so they don't worry about gaining weight. I don't think those people care if it's going to keep 'em skinny though, they just wanna quit smoking.
There's also potential with: "Lief" and: "Leaf" and I think: "Believe" is part of the Belviq ad campaign? So we could go with: "Belief." Ha! That is pretty fork & good valmontxii. Look, I've just referred to myself in the third person.
That tells me it is time to wrap it up. Okay wait, what I ACTUALLY thought they'd name the new smoking cessation drug? ADP68 because Jack Lief drives around San Diego in a car which harbors the infamous license plate that is simply: "69." Yeah, weird huh? He is a real smooth dawg and that attracts the ladies even at his age so he is still advertising 69. I mean, he even wears football jersey's into the office with a big ol' 69 on it and snaps his fingers like he's a real disco cat. The BOD is hypnotized by this swinger-like, happy-go-lucky franchise he swaggers. Then the BOD grants him options and they hit the dance clubs.
ADP68 is just the miracle of mathematics because when you take away that last nail in the coffin? (that equals a -1 btw) Well, 69-1=68. So Belviq smoking cessation will prolly be ADP68. Belief it. Or my third name is not Belvederrier.
Sentiment: Strong Buy
Nice. Short at 4.48 and close at 5.85. That's about 1.37/4.48 or 31% of your capital in just a few hours.
I'm sure you can make it all back if you double-down on that short in the morning.
You remind me of Vladimir Putin.
RG1 over on the IV board says the company needs a new CEO.
He would know too coz he's super-smart and is apparently very upside down with the long downtrend we've experienced. He wants head to roll at headquarters because of his losses. He's mad as he'll and he's not going to take it anymore by golly!!
Some of the foundation of ARNA that I personally find interesting comes out of this 2007 article from Forbes:
"Arena was founded in San Diego by Lief, a veteran drug executive with experience at Abbott and Cephalon (nasdaq: CEPH - news - people ), and researchers Dominic Behan and Derek Chalmers, who had both left San Diego biotech Neurocrine Biosciences (nasdaq: NBIX - news - people ) to pursue novel ideas about drug development.
At the time, the hot research area was in testing G-protein-coupled receptors, or GPCRS. These proteins transmit chemical signals into a wide variety of cell types. In the brain GPCRS are associated with mood and behavior; in the immune system they're linked to inflammation. Drugmakers looked for proteins called ligands, which dock to specific GPCRS, and then created a drug that either blocked or enhanced the ability of the ligand to connect with its receptor. Eli Lilly (nyse: LLY - news - people )'s Zyprexa, Glaxo's Zantac and Novartis (nyse: NVS - news - people )' Zelnorm are all GPCR-related drugs.
Behan, a native of Liverpool, England with a doctorate in biochemistry, believed he could come up with drug candidates without knowing the ligand part of the equation. That would allow Arena to target the hundreds of so-called orphan GPCRS that have no known ligands. "Think of it as an opportunity to hot-wire any car in an airport parking lot without having the key," says Lief."
That's how they do our pipeline and no big pharma has been able to attain the results these guys have achieved. The list of their candidates is a mile long and frankly, quite amazing if you ask me.
how did you know this is the place where everybody exchanges their inside information?
i guess the word has gotten out about the inside stuff being written about on yahoo.
you just ruined it for everybody.
Margin is a foolish thing to do, imo. That'll ruin it for you and for everybody else if whomever is behind all this sees a bunch of THAT going on. And they will know. And if it makes sense they will put blood in the water. Your blood. But that's just what NORMALLY happens like most of the time. To my observances anyway.